TIE Kinetix NV
AEX:TIE
TIE Kinetix NV
AEX:TIE
Price:
31.8
EUR
0.63%
Market Closed
Market Cap:
€63.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
TIE Kinetix NV
AEX:TIE
|
NL |
|
Gaxos.AI Inc
NASDAQ:GXAI
|
US |
|
Edenville Energy PLC
LSE:EDL
|
UK |
|
M
|
Mega Study Co Ltd
KOSDAQ:072870
|
KR |
|
B
|
Binhthuan Agriculture Services JSC
VN:ABS
|
VN |
|
Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES
|
IN |
|
V
|
Vaiv Company Inc
KOSDAQ:301300
|
KR |
|
C
|
China Jo-Jo Drugstores Holdings Inc
NASDAQ:CJJD
|
CN |
|
Clariant Chemicals India Ltd
NSE:CLNINDIA
|
IN |
|
Capricorn Energy PLC
LSE:CNE
|
UK |
|
GoPro Inc
NASDAQ:GPRO
|
US |
|
Burcelik Vana Sanayi ve Ticaret AS
IST:BURVA.E
|
TR |
Balance Sheet
Balance Sheet Decomposition
TIE Kinetix NV
TIE Kinetix NV
Balance Sheet Decomposition is not available for
TIE Kinetix NV
TIE Kinetix NV
Balance Sheet
TIE Kinetix NV
TIE Kinetix NV
Currency: EUR
| Sep-2013 | Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
2
|
2
|
1
|
2
|
6
|
10
|
10
|
|
| Cash Equivalents |
0
|
1
|
1
|
2
|
2
|
1
|
2
|
6
|
10
|
10
|
|
| Total Receivables |
3
|
4
|
4
|
3
|
4
|
4
|
3
|
5
|
2
|
3
|
|
| Accounts Receivables |
2
|
4
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
|
| Other Receivables |
0
|
1
|
1
|
1
|
2
|
1
|
1
|
3
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
3
|
6
|
6
|
7
|
6
|
5
|
5
|
11
|
12
|
12
|
|
| PP&E Net |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
2
|
3
|
3
|
3
|
4
|
4
|
4
|
3
|
3
|
3
|
|
| Goodwill |
2
|
5
|
5
|
5
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Note Receivable |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Other Assets |
2
|
5
|
5
|
5
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
9
N/A
|
16
+77%
|
16
-1%
|
16
+2%
|
12
-23%
|
11
-11%
|
12
+4%
|
18
+55%
|
19
+4%
|
20
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
1
|
2
|
2
|
2
|
1
|
1
|
0
|
1
|
0
|
0
|
|
| Short-Term Debt |
0
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
3
|
4
|
3
|
4
|
5
|
5
|
6
|
5
|
5
|
6
|
|
| Total Current Liabilities |
5
|
8
|
9
|
8
|
7
|
6
|
7
|
7
|
6
|
8
|
|
| Long-Term Debt |
0
|
2
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
5
N/A
|
10
+102%
|
11
+15%
|
9
-22%
|
8
-14%
|
6
-19%
|
8
+31%
|
8
0%
|
7
-8%
|
9
+23%
|
|
| Equity | |||||||||||
| Common Stock |
57
|
58
|
58
|
61
|
61
|
61
|
0
|
62
|
0
|
0
|
|
| Retained Earnings |
52
|
52
|
54
|
54
|
57
|
57
|
0
|
52
|
47
|
49
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
58
|
60
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
6
+47%
|
4
-28%
|
7
+65%
|
5
-34%
|
5
+3%
|
3
-29%
|
10
+184%
|
11
+13%
|
11
-3%
|
|
| Total Liabilities & Equity |
9
N/A
|
16
+77%
|
16
-1%
|
16
+2%
|
12
-23%
|
11
-11%
|
12
+4%
|
18
+55%
|
19
+4%
|
20
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
